14 /100
LOW RISK
Score updated May 29, 2026

TARS — Tarsus Pharmaceuticals, Inc. Dilution Risk Tracker

Track TARS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track TARS — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for TARS.
🔔 Track TARS — Get forecast alerts →

💹 Market Data

Market Cap$2.56B
Shares Outstanding43.02M
Float32.12M
Cash$388.73M
Debt$88.68M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 0.8% shares (2025Q4 vs prior)
247 institutional holders · 45.50M shares
#1 BlackRock, Inc. 3.79M shares
#2 RTW INVESTMENTS, LP 3.34M shares
#3 Deep Track Capital, LP 3.00M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.82M
Days to Cover7.5
% of Float15.0%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2020
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track TARS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking TARS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for TARS
📊 TARS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 TARS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.